Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing R&D Expenditure for the Development of Protein Labeling
4.2.2 Increasing Proteomics Research
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Reagents & Kits
5.1.2 Services
5.1.3 Other Products
5.2 By Application
5.2.1 Immunological Techniques
5.2.2 Cell-based Assays
5.2.3 Fluorescence Microscopy
5.2.4 Protein Microarrays
5.2.5 Mass Spectrometry
5.3 By Labeling Method
5.3.1 In-vitro Labeling
5.3.2 In-vivo Labeling
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 General Electric Company
6.1.2 Perkinelmer Inc
6.1.3 Thermo Fisher Scientific Inc
6.1.4 Merck & Co Inc
6.1.5 F. Hoffmann-La Roche AG
6.1.6 Kaneka Corporation
6.1.7 Promega Corporation
6.1.8 Li-Cor Inc
6.1.9 New England Biolabs Inc
6.1.10 SeraCare Life Sciences Inc


7 MARKET OPPORTUNITIES AND FUTURE TRENDS